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Diagnosing the etiologic agent of pneumonia has an essential role in ensuring the most appropriate and effective
therapy for individual patients and is critical to guiding the development of treatment and prevention strategies.
However, establishing the etiology of pneumonia remains challenging because of the relative inaccessibility of
the infected tissue and the difficulty in obtaining samples without contamination by upper respiratory tract
secretions. Here, we review the published and unpublished literature on various specimens available for the
diagnosis of pediatric pneumonia. We discuss the advantages and limitations of each specimen, and discuss the
rationale for the specimens to be collected for the Pneumonia Etiology Research for Child Health study.
Diagnosing the microbiological etiology of pneumonia
is challenging because the site of infection (ie, lung
tissue) is not easily accessible for specimen collection.
Sterile site specimens are the ‘‘gold standard’’ for the
diagnosis of invasive disease, but specimens from the
respiratory tract are accessed most easily through non-
sterile approaches. Development of a more complex gold
standard incorporating a number of methods has been
suggested [1]. The problem of appropriate specimen
collection and testing in episodes of pneumonia among
infants and children is magnified in settings in the de-
veloping world because of the reduced capacity for
clinical procedures and because of limited diagnostic
facilities; paradoxically, these settings have the greatest
prevalence of severe respiratory illness [2, 3]. Advances
in pneumonia diagnostics have made it possible to
identify a wide variety of pathogens through directed
molecular testing. As a result, when body fluid or tissue
is collected, careful consideration must be given to
handling it in ways that maximize its use for a wide range
of diagnostic assays.
We sought to establish a foundation of evidence on
which to base decisions about specimen collection
for the purpose of the PERCH study (Pneumonia
Etiology Research for Child Health; a multisite case-
control study of pneumonia etiology in the developing
world), taking into consideration the range of body fluid
and tissue specimens from which relevant data might be
obtained, the clinical and laboratory resources available
in developing country settings, patient safety, the case-
control study design, and the aim of future pathogen
discovery. We reviewed the published and unpublished
literature to formulate a rational approach, aiming to
minimize the influence of a priori notions of expected
pneumonia etiology. Here, we discuss various body fluid
or tissue specimens and the rationale for the PERCH
specimen collection algorithm.
SPECIMENS FOR DETERMINING THE
ETIOLOGY OF PNEUMONIA
Lung Aspirates
From a diagnostic standpoint, the ideal way to deter-
mine the etiology of pneumonia is to obtain a specimen
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directly from the location of the infection (ie, the lung). Lung
aspirates, commonly used for the cytological evaluation of
suspected malignancy, can also be used to detect infection. In
the developed world, the need to identify the etiology of
pneumonia is less pressing because mortality due to pneu-
monia is a rare event; access to care and to broad-spectrum
antibiotics have obviated the need for lung aspirates except
in the case of recalcitrant infection in immunocompromised
hosts. However, in the developing world, pneumonia kills
more than a million children every year and there is a real
need to determine etiology; in this context, the role of lung
aspirates is discussed below.
The general technique used for pediatric lung aspiration is
to (1) insert a needle blindly over the top of a rib into the
area of consolidation (identified by chest radiograph or
maximum physical findings), avoiding the area near the
heart, great vessels, or other vital structures; (2) apply suc-
tion to the plunger of the syringe, and (3) withdraw the
needle, while maintaining constant suction. The procedure
is performed under sterile conditions and the aspiration
takes 2–3 seconds. The primary risks associated with lung
aspiration are pneumothorax and hemoptysis. A review of
.2500 children undergoing needle aspiration over the past
8 decades from around the world reported complications
in 5% (including pneumothorax in 3.2% and chest tube
drainage required in 0.5%) [4]. In .6000 procedures in
adults and children, death was temporally, though not nec-
essarily causally, associated with lung aspiration in 6 patients
(0.1%) [5]. In more recent years, the occurrence of adverse
events following lung aspiration has decreased, presumably
because of greater awareness of risks and improvements in
technique (eg, use of smaller-gauge needles). In our review of
all published pediatric lung aspirate procedures from the past
25 years, transient minor complications were reported in 25
(3.9%) of 690 procedures and pneumothorax requiring chest-
tube drainage in 2 (0.3%); there were no deaths related to the
procedure (Supplementary Table A). Conditions that predis-
pose to bleeding or pneumothorax (eg, coagulopathy, chest
hyperexpansion, chest cysts or bullae, suspected Pneumocystis
jirovecii infection) are usually considered contraindications to
lung aspiration.
The diagnostic yield of lung aspirate culture among pedi-
atric patients with a clinical syndrome and chest radiographic
findings of pneumonia varies depending on the technique,
setting, and tests performed, but studies from the past 25 years
have reported yields of 17%–78% [4, 6, 7]. A normal, healthy
lung rarely contains sufficient organisms to produce a positive
culture in the aspirate specimen; hence, the specificity of the
technique is very high. Negative results are not uncommon
when relying on culture, but the use of molecular techniques
improves the yield considerably [8, 9]. Identification of an
etiologic agent has been reported to be similar among pa-
tients with lobar pneumonia (50%) or bronchopneumonia
(55%) [4]; however, in recent studies, the procedure has
been performed only in children with a distinct peripheral
consolidation [6–8].
Although there have been no randomized studies of the
clinical benefit of lung aspiration, a comparison of outcomes
among children in Papua, New Guinea, undergoing lung as-
piration with children from the same ward in the previous
year without lung aspiration suggested that mortality from
pneumonia was lower during the year that lung aspirates were
utilized [10]. Although this comparison reportedly involved
children with pneumonia of equal severity, it is possible that
selection bias may have contributed to this finding. None-
theless, outcomes may be improved in children undergoing
lung aspiration because of the ability to provide pathogen-
directed antimicrobial therapy. In many cases, the pathogen
identified on lung aspirate culture is not susceptible to World
Health Organization–recommended empiric antibiotics and
treatment regimens are altered accordingly [7, 11].
Children in whom lung aspirates are performed are not
representative of all children hospitalized with pneumonia
because of the application of selection criteria for the pro-
cedure. In addition, some centers may be unable to perform
lung aspirates because of practical restrictions (eg, the lim-
ited availability of a radiographer or radiographic equip-
ment). Although this will bias a group of patients toward
a subpopulation of radiographically evident cases that are
sometimes less severe, the information gained from lung
aspirates is valuable for individual patient management and
remains the most conclusive information available on the
etiology of pneumonia. The technique can be used in settings
that have the capacity for careful monitoring (eg, nursing
observations, pulse oximetry, and chest radiography) and
managing complications effectively (eg, equipment and ex-
pertise in chest-tube placement).
Lower Respiratory Tract Secretions
Secretions from the lower respiratory tract (LRT) of children
with pneumonia are of diagnostic importance because this
specimen comes from the site of infection and can be col-
lected in a noninvasive fashion from the vast majority of
cases. Children have difficulty expectorating sputum, pri-
marily because they swallow it, so it is necessary to use
bronchoalveolar lavage (BAL) or sputum induction to col-
lect an LRT specimen.
Several studies have documented the diagnostic utility of
BAL (bronchoscopic or nonbronchoscopic) in intensive care
unit settings, particularly for the diagnosis and management of
ventilator-associated pneumonia [12–15]. However, because of
the need for mechanical ventilation, the possible need to
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anaesthetize or sedate small children prior to the procedure,
and the degree of clinical training and support to assure the
safety of patients, BAL is not ideal for a study of community-
acquired pneumonia among infants and children in resource-
poor settings.
Sputum induction is most often used to diagnose pneu-
monia in settings with high tuberculosis prevalence [16] and
among children with cystic fibrosis [17, 18]. However, it has
also been demonstrated to be useful in children hospitalized
with community-acquired pneumonia [19, 20]. The meth-
odology, risks, benefits, and diagnostic yield of induced
sputum sampling are reviewed by Grant et al [21]. In brief,
the most common method for sputum induction is admin-
istration of hypertonic saline via nebulizer, followed by
percussion of the chest wall to mobilize secretions. The
sputum may be expectorated directly or collected using
a suction catheter inserted into the pharynx. The procedure
is well tolerated, although minor side effects of coughing,
vomiting, and wheezing may occur. To minimize contami-
nation of the sputum specimen by secretions from the or-
onasopharynx, suction is applied to the catheter only after it
has been inserted into the pharynx and is discontinued be-
fore it is withdrawn.
Even with meticulous technique, contamination from the
pharynx commonly occurs and bacterial culture results and
nucleic acid detection tests of induced sputum must be in-
terpreted carefully to determine whether detection of a po-
tential pathogen represents contamination from the upper
respiratory tract or disease in the LRT. The availability of
paired induced sputum and lung aspirate specimens from
the PERCH study will test the validity of induced sputum
diagnostic testing.
Pleural Fluid
Diagnostic testing on pleural fluid can be useful among the
subset of children who have pneumonia complicated by
pleural effusion. The technique for specimen collection is
well established and routinely used in clinical medicine.
Standard tests include Gram stain for bacterial culture and
Ziehl-Neelsen stain for mycobacterial culture, but anti-
gen testing and polymerase chain reaction (PCR) increase
diagnostic yield substantially [22–24].
Upper Respiratory Tract Specimens
The oropharynx (OP) and nasopharynx (NP) are 2 of the
most common portals for the introduction of microorga-
nisms into the respiratory tract. However, the detection of
a pathogen in the upper respiratory tract (URT) is neither
necessary nor sufficient evidence of the cause of pneumonia.
The etiological significance of detecting microorganisms in
the naso-oropharynx during an acute episode of pneumonia
can be difficult to interpret against a background of asymp-
tomatic colonization, replication, or persistence of genetic
material beyond the period of acute infection. Nevertheless,
for many infections, identification of the organism in the
URT provides circumstantial evidence of causality.
We considered 4 sampling methods for PERCH: naso-
pharyngeal swabs, nasal aspirates, nasal washes, and throat
swabs (Supplementary Table B). A fifth sampling method,
collecting nasal discharge by wiping the patient’s nose on
tissue paper, shows promise as a less uncomfortable alter-
native to NP swab sampling among children with coryza
[25]. We did not consider this technique for PERCH
because many case and control subjects are unlikely to
have sufficient nasal discharge.
Any of these URT specimens may be assayed by a variety
of methods to detect a variety of pathogens (see reviews
by Bhat et al and Murdoch et al [26, 27]). The ideal specimen
to detect viruses depends on the type of assay being per-
formed. In studies using direct fluorescent-antibody assay
testing or reverse transcription PCR, the sensitivity of NP
swabs (particularly flocked swabs) for detection of respira-
tory viruses is comparable to nasal wash or aspirate speci-
mens [28–30]. Compared to NP swabs, nasal aspirates and
nasal washes are more technically challenging, and because
of aspiration risk, are not practical in very severely ill chil-
dren in resource-poor settings. In addition, nasal aspirates
and washes are likely to be less acceptable to healthy control
children than an NP swab. For these reasons, we considered
the NP swab as the preferred method of URT sampling for
detection of viruses in PERCH.
OP swab specimens have been found to be consistently
less sensitive than NP specimens for a variety of viruses;
however, maximum sensitivity is attained by using multiple
types of specimens [31–33]. An OP swab can increase the
molecular detection of viral pathogens by 15% over an NP
swab alone [34] and has been found to be more sensitive
for the detection of certain viruses [35]. It is not known
whether the increase in detection is related to pathogen
tropism for different anatomical sites (eg, 2009 pandemic
influenza A for the oropharynx) or simply a result of testing
additional sample material; however, collection of an OP
swab is quick, simple, involves minimal risk, and is likely to
be acceptable to healthy controls. The cost of consumables
can be reduced by placing the OP swab and NP swab into
the same vial for transport and testing. The impact of OP
swab composition on test performance is unknown.
For bacteria that are not commonly found in the upper
airways (eg, Bordetella pertussis and Mycoplasma pneumoniae),
detecting them in NP or OP specimens by PCR and/or cul-
ture provides useful diagnostic information. However, for
most bacterial pathogens, as with most viruses, it is unclear
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whether detection in the NP has any predictive value
in defining the etiology of pneumonia. This is particularly
true for pathogens that are frequently detected in the upper
airways of children (eg, Streptococcus pneumoniae, Haemo-
philus influenzae, Staphylococcus aureus). For some pneu-
mococcal serotypes that are rarely found in the NP but
are well-recognized causes of invasive disease (eg, serotype
1 [36]), identification in the NP at the time of pneumonia
may be highly predictive of pneumococcal pneumonia.
Similarly, the absence of a pathogen in the NP at the time of
pneumonia might suggest that it is not the etiological agent
(ie, high negative predictive value). Quantification of bac-
terial load in NP specimens may help differentiate coloni-
zation from disease in the context of pneumonia, but only
very limited information is available at present [37, 38].
For the culture of pneumococci from NP swabs, there is
some evidence that rayon swabs perform better than Dacron
swabs [39]. It is recommended that swabs be transported and
stored in skim milk-tryptone-glucose-glycerin (STGG) prior
to bacterial culture [40]; however, swabs targeted for molec-
ular testing are typically transported in viral or universal
transport media, meaning that at least 2 URT specimens are
required for both culture and PCR. Recently, it has been
shown that the sensitivity of PCR for viral respiratory
pathogens (respiratory syncytial virus, influenza A, influenza
B, and adenovirus) in swabs stored in STGG is 87% (95%
confidence interval, 79.4–93.1) compared with swabs stored
in universal transport media, suggesting that it may be pos-
sible to do both PCR and culture on a single swab [41].
URT specimens can be collected on all children with
pneumonia so there is no sampling bias. A case-control de-
sign in which URT samples are collected from cases and
controls using identical materials and techniques will facil-
itate statistical testing of the association between pathogen
detection and pneumonia.
Blood Specimens
A variety of tests can be performed on blood to diagnose
pneumonia. A comprehensive review of this subject is pro-
vided by Murdoch et al [27]. Given that a limited amount of
blood can be obtained for clinical and research purposes,
it is important to consider the most efficient uses of this
valuable specimen.
Although positive blood cultures are found in only a small
minority of children hospitalized with pneumonia, organisms
identified by blood culture are widely accepted to be indi-
cative of etiology of pneumonia, and antibiotic susceptibility
results from these pathogens are used to guide therapy [6, 15].
The yield of blood cultures can be improved with careful
attention to the volume of blood inoculated, the ratio of
specimen volume to media, the minimization of specimen
contamination, the optimization of storage, transport, and
incubation conditions, and the ensuring of adequate micro-
biological capacity to evaluate positive culture bottles. Addi-
tional diagnostic information may be gained by doing PCR
on blood culture specimens that flag positive on an automated
culture instrument but are negative on subculture [42, 43].
It is expected that blood cultures from well children in the
community would rarely, if ever, be positive for a pathogen
[44] and that significant costs could be incurred solely from
the evaluation of contaminated cultures; therefore, blood
cultures from control subjects are not recommended.
Serological testing of acute or paired acute/convalescent
samples was one of the earliest techniques developed for the
diagnosis of pneumonia etiology and continues to be used
today [45–47]. Serology may be useful in detecting fastidious
pathogens, and it may provide supportive evidence for an
association between detection of a pathogen in the URT and
pneumonia. This type of association analysis may be par-
ticularly useful for pathogens that are known to have pro-
longed shedding in the nasopharynx or are highly prevalent
in a control population.
Additional blood tests that provide information for the
diagnosis of pneumonia include assessments of risk factors
(eg, malaria, hemoglobinopathy, human immunodeficiency
virus [HIV] infection) and biomarkers (eg, C-reactive pro-
tein, procalcitonin). Correct interpretation of these results
necessitates that the tests be performed in both case and
control subjects.
The collection of a small volume of blood is considered to be
a minimal risk activity for patients and for control subjects.
Many of the PERCH sites have had experience in the collection
of blood from control subjects; the results of certain tests (eg,
malaria, hemoglobin, HIV) can be reported and treatment
provided if indicated. Although there are no universal guidelines
on acceptable volumes of blood that may be safely collected
from children, a recommendation has been published based on
a review of the literature [48]. Among sick children, a maximum
of 3 mL/kg over 24 hours is suggested as a reasonable guideline,
although greater caution may be needed in children with anemia
or blood volume depletion.
Urine Specimens
Several infectious causes of pneumonia can be detected by
urinary antigen tests. Although urinary antigen testing can
be used to diagnose pneumococcal pneumonia in adults,
the test lacks specificity in children as a result of the high
prevalence of pneumococcal colonization during childhood
[49]. Detection of Legionella antigenuria is both sensitive and
specific; however, this is a rare cause of pneumonia in children.
Recent studies suggest that analysis of the metabolic profile
of urine specimens may be a useful tool in differentiating
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pneumonia from other febrile illnesses and in identifying
children in whom detection of pathogens represents an
‘‘innocent bystander’’ state, rather than disease [50]. Mouse
models also suggest a possible role for metabolomics in
identifying the actual infection causing pneumonia [51–53].
Collection of a bagged urine specimen is a minimal risk
procedure and the specimen can be collected from all chil-
dren with pneumonia and from control subjects, so there is
no sampling bias. The biggest challenge in collecting this
specimen is the inability to obtain a specimen ‘‘on demand,’’
especially in patients who are ill and may be dehydrated
or anuric.
Postmortem Lung Tissue Specimens
Identification of the cause of fatal pneumonia is critical to
understanding and preventing pneumonia deaths; however,
there are considerable cultural and social constraints on
postmortem examination in many countries. Immediate
postmortem percutaneous lung biopsy offers a potentially
simpler and less invasive approach to obtain lung tissue.
A comprehensive discussion of the risks, benefits, and
methodology of postmortem lung tissue sampling is pro-
vided by Turner et al [54]. In brief, microbiological testing
of lung tissue can be used to compare postmortem and
premortem specimens on the same patient to validate
Table 1. PERCH Algorithm for Specimen Collection and Laboratory Testing in Case Subjects
Specimen Subjectsa Assay
Acute blood All (.95%) Blood culture
Pneumococcal antigen testing on blood culture
alarm (1) culture (2) specimens
Complete blood count with differential
Pneumococcus PCR
HIV test
Hemoglobinopathy testing (selected sites)
Malaria antigen testing or microscopy (selected sites)
Serologic testing
C-reactive protein, other biomarkers
Host genetic studies
Convalescent serum All (.90%) Serologic testing
Convalescent plasma Select cases
(site specific)
CD4 testing for HIV1 cases in selected sites
Urine All (.95%) Storage for future antigen testing, biomarkers
NP flocked swab All (.95%) PCR for respiratory pathogens
NP rayon swab All (.95%) Bacterial culture and serotyping for pneumococcus
Throat rayon swab All (.95%) PCR for respiratory pathogens
Induced sputum All, except when
contraindicated (.90%)
Microscopy, bacterial culture and AST
Mycobacterium tuberculosis microscopy, culture
PCR for respiratory pathogens
Lung aspirate (select sites) Select cases (,10%) Microscopy, bacterial culture and AST
M. tuberculosis microscopy, culture
PCR for respiratory pathogens
Gastric aspirate Select cases (,5%) M. tuberculosis microscopy, culture
Pleural fluid Select cases (,5%) Microscopy, bacterial culture and AST
Cell count, protein, glucose
M. tuberculosis microscopy, culture
Antigen detection (pneumococcus)
PCR for respiratory pathogens
Lung tissue (select sites) Postmortem cases (,2%) Histology and immunohistochemistry
Gram stain, bacterial culture and AST, mycobacterial culture
Multiplex PCR and 16S RNA typing
Abbreviations: AST, antibiotic susceptibility testing; HIV, human immunodeficiency virus; NP, nasopharyngeal; PCR, polymerase chain reaction; PERCH, Pneumonia
Etiology Research for Child Health; STGG, skim milk-tryptone-glucose-glycerin; VTM, viral transport media.
a Shown with the proportion of cases expected to have a specimen available.
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premortem diagnostics, and importantly, can help to es-
tablish a diagnosis where one is lacking, particularly for
children who arrive at a hospital in extremis and die shortly
after arrival, before investigations can be initiated.
Exhaled Breath Specimens
There is a growing body of literature on the use of exhaled
breath and exhaled breath condensate (EBC) to investigate
occupational lung diseases and atopic lung disease. Bio-
markers in EBC samples have also been correlated with in-
fection in several small pilot studies [55–57]. Although this is
a relatively simple specimen to collect and comes directly
from the infected site, the technique is not fully standar-
dized and the specificity of findings for pneumonia versus
other types of illness or infection has not been established.
Considerable validation studies would be required to esta-
blish normal values for biomarkers in EBC in children with
pneumonia and to ascertain specific associations between
EBC values and lung pathology. For these reasons, this novel
technique was not recommended for collection in PERCH
subjects.
SPECIMEN STORAGE AND TRANSPORT
Assuring the quality and standardization of specimen transport,
storage and laboratory testing across PERCH study sites is
a fundamental activity for the success of the project. Specimen
transport and storage are subject to a standard operating
procedure so that the conditions under which these activities
take place are standardized across all sites (Supplementary Table
C). In addition, a Lab Quality Plan establishes guidelines for
quality assurance/quality control activities at each PERCH
site, including a system for external quality assessment.
CONCLUSIONS
The PERCH specimen collection algorithm, summarized in
Table 1 for cases and Table 2 for controls, focuses on tests of
inherently high specificity (lung aspirates, pleural effusion)
but also includes induced sputum and upper respiratory
tract sampling to provide a minimum of information on the
vast majority of pneumonia patients. PERCH will rely on
epidemiological and statistical approaches to interpret re-
sults (especially in children with positive assays for multiple
pathogens or discordant results from different specimens)
and attribute causality [58].
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